Inventor · disambiguated record
Ralf Baumeister
Also filed as: BAUMEISTER RALF
6 granted patents·6 pending applications·17 citations·filing 1997–2014
75Inventor score
Files withSANOFI AVENTIS DEUTSCHLAND3AVENTIS PHARMA GMBH2ELEGENE GMBH1HOENER MARIUS1LUDWIG MAXIMILLIANS UNI MUNCHE1
Top patents by PatentIndex Score
12 records- 0155US2007293450A1Identification of ses-3 and the uses of sameSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Application pending·0 cites
- 0253US6702996B1Method for investigating the suitability of a material as a medicamentAVENTIS PHARMA GMBH·Filed 2000·Granted Mar 9, 2004·4 cites·9 claims
- 0348US8193408B2Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode geneHOENER MARIUS·Filed 2008·Granted Jun 5, 2012·0 cites·2 claims
- 0446US6673600B2Transgenic C. elegans as a model organism for investigations on Alzheimer's diseaseAVENTIS PHARMA GMBH·Filed 1999·Granted Jan 6, 2004·9 cites·4 claims
- 0546US2008168573A1Identification of ses-1 and the uses of the sameSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 0640US2005059586A1Identification of ses-3 and the uses of the sameFiled 2002·Application pending·0 cites
- 0739US7399900B2Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode geneSANOFI AVENTIS DEUTSCHLAND·Filed 2001·Granted Jul 15, 2008·0 cites·9 claims
- 0836US6376239B1DNA molecules comprising a promoter capable of conferring expression of a heterologous DNA sequenceELEGENE GMBH·Filed 1997·Granted Apr 23, 2002·4 cites·10 claims
- 0933US2005054592A1Identification of ses-1 and the uses of the sameFiled 2002·Application pending·0 cites
- 1033US2009053196A1Chn-1/Chip-Antagonists For The Treatment Of Muscular DiseasesLUDWIG MAXIMILLIANS UNI MUNCHE·Filed 2005·Application pending·0 cites
- 1132US10041933B2Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapyUNIV FREIBURG ALBERT LUDWIGS·Filed 2014·Granted Aug 7, 2018·0 cites·6 claims
- 1232US2003108893A1Method for establishing neurogically relevant properties of a materialFiled 2000·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →